These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 32578904)

  • 1. Emerging use of senolytics and senomorphics against aging and chronic diseases.
    Martel J; Ojcius DM; Wu CY; Peng HH; Voisin L; Perfettini JL; Ko YF; Young JD
    Med Res Rev; 2020 Nov; 40(6):2114-2131. PubMed ID: 32578904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp90 inhibitors as senolytic drugs to extend healthy aging.
    Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD
    Cell Cycle; 2018; 17(9):1048-1055. PubMed ID: 29886783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging senolytic agents derived from natural products.
    Li W; Qin L; Feng R; Hu G; Sun H; He Y; Zhang R
    Mech Ageing Dev; 2019 Jul; 181():1-6. PubMed ID: 31077707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senolytic drugs: from discovery to translation.
    Kirkland JL; Tchkonia T
    J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation.
    Wyles SP; Tchkonia T; Kirkland JL
    Plast Reconstr Surg; 2022 Oct; 150():20S-26S. PubMed ID: 36170432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for late phase preclinical and early clinical trials of senolytics.
    Wissler Gerdes EO; Misra A; Netto JME; Tchkonia T; Kirkland JL
    Mech Ageing Dev; 2021 Dec; 200():111591. PubMed ID: 34699859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Senescence: A Translational Perspective.
    Kirkland JL; Tchkonia T
    EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.
    Romashkan S; Chang H; Hadley EC
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1144-1152. PubMed ID: 33528569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology.
    Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE
    Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular senescence in age-related disorders.
    Kaur J; Farr JN
    Transl Res; 2020 Dec; 226():96-104. PubMed ID: 32569840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Senescence in Idiopathic Pulmonary Fibrosis.
    Kellogg DL; Kellogg DL; Musi N; Nambiar AM
    Curr Mol Biol Rep; 2021; 7(3):31-40. PubMed ID: 34401216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senolytics: A Translational Bridge Between Cellular Senescence and Organismal Aging.
    Thoppil H; Riabowol K
    Front Cell Dev Biol; 2019; 7():367. PubMed ID: 32039197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases.
    Matsubayashi S; Ito S; Araya J; Kuwano K
    Front Endocrinol (Lausanne); 2023; 14():1079626. PubMed ID: 37077349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.